GCG and obesity disorder: A glucagon-like peptide 1 (GLP-1) analog called Liraglutide has been used to treat obesity and diabetes and is being assessed in an ongoing clinical trial to improve brain glucose metabolism as well as cognition in patients with mild AD (Femminella et al., 2019).